Related Experiment Video
Updated: Jun 23, 2026
12:45
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Cardiac resynchronization therapy in NYHA class IV heart failure
Michelle Khoo1, Patricia A Kelly, JoAnn Lindenfeld
1University of Colorado Health Sciences Center, 1635 Aurora Court, F749, Aurora, CO 80045, USA.
Current Cardiology Reports
|April 22, 2009
Summary
Cardiac resynchronization therapy (CRT) shows benefits for heart failure patients but has limitations. Further research is needed for specific patient groups and as rescue therapy.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Clinical guidelines recommend cardiac resynchronization therapy (CRT) for specific heart failure patients (NYHA class IV, QRS duration ≥ 120 ms, LVEF ≤ 35%).
- Limited prospective data exist comparing CRT outcomes in NYHA class III and IV patients.
- Existing trials primarily included patients in sinus rhythm with left bundle branch block.
Purpose of the Study:
- To evaluate the effectiveness of cardiac resynchronization therapy (CRT) in heart failure patients, particularly those with complex conditions.
- To explore the potential of CRT as a rescue therapy for inotrope-dependent patients.
Main Methods:
- Review of existing prospective, randomized trials comparing CRT outcomes.
- Analysis of case series data for CRT as rescue therapy in inotrope-dependent patients.
Main Results:
- CRT improved mortality, exercise capacity, and quality of life in NYHA class IV patients, though 1-year mortality remained high.
- Data are scarce for NYHA class IV patients with atrial fibrillation, right bundle branch block, or prior ventricular pacing.
- Case series suggest promising results for CRT as rescue therapy, potentially enabling withdrawal of inotropic support and reintroduction of guideline-directed medical therapy.
Conclusions:
- Cardiac resynchronization therapy (CRT) offers benefits for select heart failure patients but requires further investigation in specific subpopulations.
- CRT may serve as a valuable rescue therapy, particularly when it facilitates the reintroduction of optimal medical management.
- More data are needed for patients with atrial fibrillation, RBBB, and those with prior ventricular pacing to fully understand CRT's role.
Related Concept Videos
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...